Clinical Trialist Development Award (CTDA)

A prestigious award that provides protected time for 2 years (0.2 FTE for Clinical Trialist; 0.4 FTE for Master Clinical Trialist), with the aim to develop clinicians with expertise and interest in the conduct of clinical trials.

The CTDA promotes recognition for the pursuit of clinical research and demonstrates institutional and national prestige. It supports the endeavours of Clinical Trialists at varying levels to deepen focus on research efforts through clinical trials and ensure quality care and patient safety.

Application is closed for 2024.

For more information, look out for the next Call for Applications in 2025.

Infosheet

1. Clinical Trialist Development Award_Infosheet

Eligibility & Evaluation Criteria

Each submission must be made using the prescribed forms:

Clinical Trialist Development Award Application Form (to be completed by applicant)
Applicant CV & Career Development Plan (to be completed by applicant)
Nomination Form (to be completed and endorsed by Clinical HOD, ACP Chair and SDDC Head (where applicable)).

Please click here for more information and application materials.

Applications that fail to comply with requirements in any of the templates and/or incomplete applications will be disqualified and will not be reviewed.

Proposals should define clear and measurable deliverables / outcomes.
The criteria of the applicant and the expected outcomes are as follow:

	Clinical Trialist	Master Clinical Trialist
Criteria	A Clinician who: Is a PI of 2 or more Clinical Trials in the past 2 years; Secured trial contract value of >S$500,000 over a 2-year period and Achieved average recruitment target of ≥50% for all the trials in the past 2 years OR Is overall Chief PI of Investigator Initiated Clinical Trial who has designed the trial and secured funding for the trial with contract value of >S$500,000	A Clinician who: Is a PI of 5 or more Clinical Trials in the past 2 years;　 Secured trial contract value of >S$1 million over a 2-year period and Achieved recruitment target of ≥50% for all the trials in the past 2 years OR Is overall Chief PI of Investigator Initiated Clinical Trial who has designed the trial and secured funding for the trial with contract value of >S$1 million
Protected Time	0.2 FTE per individual, to be reviewed every 2 years	0.4 FTE per individual, to be reviewed every 2 years
KPIs	New trials, recruitment target, actualised budget, compliance, training of junior investigators	New trials and grants, recruitment target, actualised budget, compliance, mentorship and training of junior investigators, publications, guideline / policy impact

Inspiring Stories of our Clinical Trialists
Clinical Assocciate Professor Mariko Koh		Associate Professor Rebecca Dent
Recognising Our Clinical Trialists On 25 January 2022, SingHealth Duke-NUS Academic Medical Centre (AMC) launched a new Clinical Trialist Development Programme (CTDP), as a prestigious award to recognise the important work that our clinical trialists do and to also support them with much-needed protected time to do clinical trials.		Shining A Spotlight On Our Clinical Trialists Associate Professor Rebecca Dent shares about the passion she has as a clinical trialist, and why she is looking forward to the newly launched Clinical Trialist Development Programme (CTDP).


Dr Yvonne Chan
Two Hats are Better than One
As a recipient of the prestigious Clinical Trialist Development Programme CTDP Award in 2022, Dr Yvonne Chan is able to better pursue her passion to deliver patient care, both as a clinician as well as a researcher

Get in touch

For enquiries, please contact academic-medicine@duke-nus.edu.sg

Clinical Trialist Development Award (CTDA)

Infosheet

Eligibility & Evaluation Criteria

Get in touch

Prof Ivy Ng

SingHealth GCEO